Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Alzheimer's disease drug development pipeline: 2019 | Synapse

January 1, 2019Open Access

Ver artículo completo

Alzheimer's disease drug development pipeline: 2019

Jeffrey L. CummingsCleveland Clinic GLGaram LeeSeoul National University of Science and Technology ARAaron RitterCleveland Clinic

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Drug development continues robustly at all phases despite setbacks in several programs in the recent past. Continuing unmet needs require a commitment to growing and accelerating the pipeline.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Cummings et al. (Tue,) studied this question.

synapsesocial.com/papers/69dff6def3745b3748255609 https://doi.org/https://doi.org/10.1016/j.trci.2019.05.008